Genetic pancreatic disease

Genetic pancreatic disease (Orphanet code 165661) is a broad classification category encompassing a group of rare inherited disorders that primarily affect the pancreas. These conditions result from genetic mutations that impair the normal development, structure, or function of the pancreas, which plays critical roles in both digestion (exocrine function, producing digestive enzymes) and blood sugar regulation (endocrine function, producing insulin and glucagon). Diseases within this grouping may include hereditary pancreatitis, congenital pancreatic malformations, Shwachman-Diamond syndrome, Johanson-Blizzard syndrome, and various forms of monogenic diabetes, among others. Because this is a classification group rather than a single disease entity, the clinical presentation varies widely depending on the specific underlying condition. Patients may experience recurrent episodes of pancreatitis (abdominal pain, nausea, vomiting), exocrine pancreatic insufficiency (malabsorption, steatorrhea, failure to thrive), or endocrine dysfunction (diabetes mellitus). Some conditions present in the neonatal period or infancy, while others may not manifest until adulthood. Additional organ systems may be involved depending on the specific genetic syndrome. Treatment is tailored to the specific diagnosis within this group and is largely supportive. Management strategies may include pancreatic enzyme replacement therapy for exocrine insufficiency, insulin therapy for diabetes, nutritional support, pain management for pancreatitis, and in severe cases, surgical intervention. Genetic counseling is recommended for affected families. Advances in genetic testing have improved diagnostic accuracy, enabling earlier identification and more targeted management of these conditions.

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Common questions about Genetic pancreatic disease